LSD molecule:

Image from PubChem

LSD Clinical Trials


A Randomized, Double-blind, Placebo-controlled, Crossover Study to Evaluate the Abuse Potential of Sativex in Subjects With a History of Recreational Marijuana Use


To see complete record on clinicaltrials.gov, please visit this link

Id: NCT01323569

Organisation Name: GW Pharmaceuticals Ltd.

Overal Status: Completed

Start Date: February 2008

Last Update: June 14, 2013

Lead Sponsor: GW Pharmaceuticals Ltd.

Brief Summary: This crossover study with six treatment sessions is to evaluate the abuse potential of three doses of Sativex as compared to Marinol and placebo, in subjects with a history of recreational marijuana use.

Conditions:
  • Evaluation of Abuse Potential of Sativex


Total execution time in seconds: 0.20981502532959